Scott Barrett

Scott Barrett currently serves as Senior Vice President and Head of Clinical Development at Verastem Oncology and as Chief Clinical Officer at ViridBio Solutions, where responsibilities include developing novel diagnostics for viral-associated diseases and providing medical monitoring and regulatory consulting services. Previous roles include Chief Medical Officer at Immuneering Corporation and Executive Director of Global Medical Affairs Clinical Lead for Targeted Therapeutics at Incyte Pharmaceuticals. Scott Barrett also held the position of Senior Director for Oncology Research & Development at Infinity Pharmaceuticals, focusing on the lymphoma program. Educational background includes a Medical Oncology Fellowship from Memorial Sloan-Kettering Cancer Center and an Internal Medicine Internship & Residency from Mayo Clinic.